Clinical trial

Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and…

NCT00475332 · University of Florida, Other · Terminated

Key facts

NCT number NCT00475332
Title Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
Official title Feasibility Study of External Beam Radiotherapy and Iodine-131 Tositumomab (Bexxar) for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma
Lead sponsor University of Florida, Other
Collaborators GlaxoSmithKline Industry
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Non-Hodgkin's Lymphoma, Follicular Lymphoma
Intervention type Drug, Procedure
Interventions Iodine I -01 Tositumomab (Bexxar), External Beam Radiation Therapy
Enrollment 2
Start date Sep 1, 2007
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted May 21, 2007
Last update posted Feb 15, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies